We have examined the synthesis and stability of ZnS quantum dots (QDs) using an all-aqueous route at pH = 12 with (3-mercaptopropyl)trimethoxysilane (MPS) as the capping molecule. The MPS-capped ZnS QDs obtained were well dispersed with a particle size around 5 nm and a cubic zinc blende crystalline structure. The QDs exhibited optimal photoluminescence (PL) emission when the MPS:Zn:S ratio was between 1/4:2:1 and 1/2:2:1. Compared with the earlier obtained ZnS QDs capped with 3-mercaptopropionic acid (MPA), the MPS-capped ZnS QDs exhibited a similar, high quantum yield, 42% and 25% for MPS:Zn:S 1/2:2:1 and 1/4:2:1, respectively, but much better photostability. With the MPS:Zn:S ratio of 1/4:2:1, we showed that at room temperature and under the normal laboratory lighting conditions, the MPS-capped QDs were able to maintain their PL intensity for more than 50 days without degradation. We further showed that the MPS-capped QDs were stable not only in their synthesis solution but also in deionized (DI) water and in phosphate buffer saline (PBS) solution. The QDs with 1/2:2:1 were able to stay at 50 degrees C for more than 20 h without degrading the PL intensity. They were also stable under continuous UV exposure for 3 h. With the high quantum yield and significantly improved photostability, the MPS-capped ZnS QDs could be good imaging tools for many biological applications.
No takes yet. Share an insight, caveat, or question.
Li et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: